MedTrace Logo

Endogenous Opioid Mechanisms for Rejection Sensitivity

NCT02189785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2020-10-22

No results posted yet for this study

Summary

This project hypothesizes that the brain's opioid system determines rejection sensitivity, a personality trait that is a vulnerability factor and feature of several psychiatric disorders. This project will use positron emission tomography to measure the brain's opioid response to social rejection and acceptance in a nonclinical population with varying levels of rejection sensitivity. The results will provide the first major step towards understanding a neurotransmitter mechanism for rejection sensitivity, allowing for further investigation into predicting and treating its associated disorders.

Conditions

  • Rejection Sensitivity

Sponsors & Collaborators

Principal Investigators

  • David T Hsu, Ph.D. · Stony Brook University

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-06-06
Completion
2019-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02189785 on ClinicalTrials.gov